Showing posts with label Molecular Medicine. Show all posts
Showing posts with label Molecular Medicine. Show all posts

Friday, April 19, 2019

Molecular Pathology of Prostate Cancer


Prostate Cancer (PCa) is the second most typically diagnosed malignancy in men and has a particularly heterogeneous clinical behaviour. PCas are hormonally driven diseases in which sex hormone plays a central role. Microarray technology has recently accelerated the study of the molecular events concerned in Prostate Cancer, giving the prospect of additional precise prognosis and new therapeutic ways.  Prostate cancer represents one in 10 cases of cancer in men. Prostate tumours, though slower growing than most tumours varies widely in their aggressiveness. The molecular pathology of Prostate Cancer is complex; multiple genes concerned in its pathologic process, however extra environmental factors like diet and inflammation are concerned.




Though getting malignant neoplasm tissue is important for this genomic and molecular identification, knowing once to a diagnostic test, choosing the acceptable pathological process the lesion, and decoding the results are major challenges facing clinicians these days. Further, prostate tumours usually acquire molecular alterations with sickness progression and treatment resistance.

The exact cause of prostate cancer is unclear, but there are many possible risk factors.
  • Age
  • Geography
  • Genetic factors
  • Diet
  • Medication
  • Obesity
We want to stop prostate cancer from being a killer. We fund groundbreaking research, drive improvements in treatment, and fight injustice in care.
Regular screening can help detect prostate cancer while it is still treatable.

  • Medical history and physical exam
  • PSA blood test
  • Transrectal ultrasound (TRUS)
  • Prostate biopsy
  • Gleason score or Grade Group

  • The imaging tests for prostate cancer include:
  • Bone scan
  • Computed tomography (CT) scan
  • Magnetic resonance imaging (MRI)
  • Lymph node biopsy

The below things listed might possibly lower your risk of prostate cancer.
  • Body weight, physical activity, and diet
  • Vitamin, mineral, and other supplements
  • Some Medicines ( 5-alpha reductase inhibitors, Aspirin)

  • Ask your doctor for a survivorship care plan
  • A suggested schedule for follow-up exams and tests
  • Diet and physical activity suggestions
  • Typical follow-up schedules after prostate cancer
  • The prostate will Cancer can recur even a few years once the treatment, that is why it’s vital to stay regular doctor visits and reports any new symptoms.


For more on these topics, Check our Conference Session Molecular Pathology

J U L Y 15-16, 2019 | D U B A I, U A E

Thursday, April 4, 2019

Stem Cells Applications in Regenerative Medicine and Disease

Regenerative medicine is a rising branch of life science which deals with the restoration of tissues or organs in severe injuries. The indefinite self-renewal and potential to differentiate into different cells represent stem cells as frontiers of regenerative medicine. The transdifferentiating potential of stem cells varies with regenerative applications. Stem cells have a capability for self-renewal and capability of proliferation and differentiation to varied cell lineages. They'll be classified into embryonic stem cells (ESC) and non-embryonic stem cells (non-ESC). ESCs have a good potential however their use remains restricted due to moral and scientific concerns.

Stem cells are applied within the treatment of significant diseases for over fifty-five years. They're applied particularly to treat cancers, that need high-dose therapy. Stem cells have a vital role in Regenerative medication analysis and have several potential applications.
Stem cells are very important to the sphere of organic process biology. This methodology is already afoot within the cancer medical care world,  for the aim of testing anti-tumor and chemotherapeutical medication. Finally, and of most interest to patients and scientists Ҝis that the role stem cells can play in Cell-Based medical care. These therapies can be applied to cell development, differentiation, and maintenance to come up with new, healthy tissue for diseases needing transplant or replacement of broken tissue like inflammatory disease, encephalopathy, polygenic disorder, and coronary unwellness. Cell therapies in the future can be ready to replace organ donation and eliminate problems like rejection and tissue insufficiency.  over the approaching decades, scientists hope to still build discoveries that may alter the potentials of cell-based medical care to become a reality.

Stem cell research is the key to developing cures for degenerative conditions like Parkinson's and motor neuron diseases which many people suffer. Advancements can benefit everyone in the regenerative medicine space. We can harness its life-giving potential in future by working together. Alzheimer's, Parkinson's, brain and spinal cord disorders, diabetes, cancer, at least 58 diseases could potentially be cured through stem cell research, diseases that touch every family in the world😮.


Session on: Stem Cell & Regeneration in Molecular Medicine Conference 2019 | July 15-16,2019 | Abu Dhabi, UAE.


Be a part of, share us your views too ⇢⇢⇢ Register Here

Friday, March 29, 2019

Precision Medicine: What it Mean for Your Health?

Precision Medicine is an approach that permits doctors to choose treatments by understanding the genetic cause of patient sickness. Precision medicine, sometimes called personalized medicine, is an approach for protecting the health and treating a disease that considers a person’s genes, behaviors, and environment. Precision drugs are most popular in areas of cancer analysis. Immunotherapy is a new approach that harnesses the power of our immune systems to identify and control diseases such as cancer. Using the genetic changes in the patient,  their treatment is understood.



Precision genetics provides a customized approach to testing, diagnosing, and treating cancer. Instead of employing a one-size-fits-all approach  here are some ways in which a precision drug approach will shield your health:
Predict susceptibility to disease
Improve disease detection
Pre-empt disease progression
Customize disease-prevention strategies
Prescribe more effective drugs
Avoid prescribing drugs with predictable side effects

The ancient follow usually misses its mark - every person’s genetic makeup is completely different from others,  which have a vital effect on health. Our understanding of genetics and the way they drive health, sickness and drug responses in everyone make doctors supply higher sickness interference, more correct diagnoses, safer drug prescriptions and simpler treatments for the numerous diseases and conditions that diminish our health. Tailoring health care to every person’s distinctive genetic makeup – that’s the promising plan behind Precision Drugs.


Uses Family Health History
Screen for Diseases Before You Get Sick
Tailoring Prevention
Tailoring Treatments
Finding and Tracking Infectious Diseases
Eliminate trial-and-error inefficiencies that inflate health care prices and undermine patient care.

Throughout history, the follow of traditional medication has mostly been reactive. Even today, we tend to wait till the onset of diseases then attempts to treat or cure them. Our efforts to treat these major diseases like Cancer, Alzheimer’s and diabetes which are caused by Genetic and environmental factors are often imprecise, unpredictable and ineffective.

The drugs and treatments we devise are tested on broad populations and are prescribed using statistical averages. Consequently, they work for a few patients not for several others, due to genetic differences among the population. On average, any given medicinal drug currently on the market solely works for half people.

Tuesday, March 19, 2019

The Promise of Bio markers in Cancer detection

Recent developments, Current trends and Future directions

One of the vital factors for the survival of cancer is detection at an early stage. Clinical assays diagnose events of cancer and stop cancer progression. Biomarkers measure molecular signatures of a cell that aid in early cancer detection and risk assessment. Cancer biomarkers are DNA, mRNA, proteins, metabolites, or processes like cell death, growth or proliferation. The markers are made either by the neoplasm itself or by alternative tissues, in response to the presence of cancer or alternative associated conditions, like inflammation. Such biomarkers are often found in fluids, tissues and cell lines.
Biomarkers give a robust and dynamic approach to understanding the spectrum of malignancies.T he goals in cancer analysis in finding biomarkers may be used for the first detection of cancers, individual therapies, and to spot underlying processes concerned the sickness.
In spite of advances, cancer remains the second leading reason behind death. Successful cancer treatment depends not solely on therapies but also on improved strategies to find cancers at early stages. Current cancer diagnostic imaging strategies are labour-intensive and expensive, particularly for screening massive populations. So, there is increasing interest in molecular markers as tools for cancer detection and prognosis.

It is hoped that high-throughput technologies would revolutionize cancer therapies by rising cancer risk assessment, early detection, diagnosis, and prognosis.  Biomarkers embrace genes and genetic variations.  By analysing biomarkers, diagnostic tests can able to give info regarding early tumour development to find cancer at the treatable stage.
These biomarkers will be useful in managing patients with the following settings:
  • Risk Assessment
  • Screening/Detection
  • Diagnosis
  • Prognosis
  • Prediction
  • Monitoring
We are delighted to welcome all participants to enjoy a rich, varied and attractive scientific and cultural program. We cordially wish you benefit from pleasant interactions with colleagues and carry home good memories of the 4th International Conference on Molecular Medicine and Diagnostics at Abu Dhabi, UAE.